For the best experience on the Abcam website please upgrade to a modern browser such as Google Chrome
ab219802 enables the highly sensitive detection of glycated proteins (advanced glycation endproducts, AGEs) using a simple polyacrylamide gel electrophoresis (PAGE)-based method. This kit is compatible with a range of biological samples, including lysates, plasma, sera or tissue homogenates.
Glucose and other metabolites of glycolysis react directly with important cellular components such as DNA, lipids and protein through a process known as glycation. During glycation, reducing sugar molecules react with the amino groups of amino acids such as those found on lysine, arginine and protein N-termini, ultimately leading to the formation of complex and stable AGEs.
This kit uses Fluorescein-phenylboronate gel electrophoresis (Flu-PAGE) to detect early glycation adducts on proteins by exploiting the reversible covalent interaction between boronic acid and cis-diols that are present in fructosamine-protein adducts in glycated proteins (Pereira Morais et al., 2013). This interaction is further strengthened by the additional charge interaction between boronate and the fructosylysine amino group (Pereira Morais et al., 2010). As the anomeric cis diols produced by this interaction are absent in N- and O-glycosylation, this method enables the specific identification of glycated proteins over glycosylated and unmodified proteins as (Pereira Morais et al., 2013; Kassaar et al., 2017). This highly sensitive method detects the earliest stages of glycation, before AGEs are developed, and thus is an ideal tool for identifying reducing sugar modified proteins in complex biological samples such as plasma and brain homogenates.
|Fluorescein||1 x 1mg|
|Fluorescein-boronic acid||1 x 1mg|
Our Abpromise guarantee covers the use of ab219802 in the following tested applications.
The application notes include recommended starting dilutions; optimal dilutions/concentrations should be determined by the end user.
|SDS-PAGE||Use at an assay dependent concentration.|
|WB||Use at an assay dependent concentration.|
A strong band corresponding to glycated Human Serum Albumin is present in fluorescein-boronic acid-treated samples (HSFB) but not in control fluorescein samples (HSF). Left: Flu-PAGE analysis of normal human serum incubated with a fluorescein-boronic acid working solution made with water. Middle: Flu-PAGE analysis of normal human serum incubated with a fluorescein-boronic acid working solution made with methanol. Right panel: Coomasie Blue staining of the Flu-PAGE gel used to create the image in the centre. Flu-PAGE gels were visualized with a blue light transilluminator using an orange (595nm) filter. Normal human serum was diluted 1:10 in buffer prior to labeling with fluorescein-boronic acid or fluorescein. M – prestained molecular weight markers.
ab219802 has not yet been referenced specifically in any publications.
Please note: All products are "FOR RESEARCH USE ONLY AND ARE NOT INTENDED FOR DIAGNOSTIC OR THERAPEUTIC USE"